All AbMole products are for research use only, cannot be used for human consumption.
Protamine sulfate is a positive ionic peptide with anti-heparin activity. Protamine sulfate has strong alkaline groups, which combine with strongly acidic heparin in the body to form a stable compound, making heparin lose its anticoagulant ability.
| Formula | H2O4S |
| CAS Number | 9009-65-8 |
| Solubility (25°C) | Water ≥ 40 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[3] Vance G Nielsen, et al. Anesth Analg. Protamine sulfate: crouching clot or hidden hemorrhage?
[4] No authors listed. J Am Med Assoc. PROTAMINE sulfate
[5] R Porsche, et al. Heart Lung. Allergy to protamine sulfate
| Related Thrombopoietin/Thrombin Products |
|---|
| BIBR 953
BIBR 953 (Dabigatran, Pradaxa) is an oral anticoagulant from the class of the direct thrombin inhibitors. |
| Enoxaparine
Enoxaparine is a low molecular heparin that binds to antithrombin (AT) and accelerates its inhibition of factor Xa.Enoxaparine has a higher affinity for factor Xa than for thrombin, and its action on thrombin does not require HCII (heparin cofactor II). |
| Dabigatran Etexilate
Dabigatran Etexilate is the procompound of dabigatran, a potent, nonpeptidic small molecule that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule. |
| Dabigatran etexilate mesylate
Dabigatran etexilate mesylate is a direct thrombin inhibitor. |
| Gallic acid
Gallic acid is an antiinflammatory substance found in plants and has been shown to Induce apoptosis in human lung cancer cells. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
